These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3492379)

  • 1. Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody.
    Harada M; Makino S
    Jikken Dobutsu; 1986 Oct; 35(4):501-4. PubMed ID: 3492379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune disturbance and pathogenesis of non-obese diabetes-prone (NOD) mice.
    Harada M
    Exp Clin Endocrinol; 1987 Aug; 89(3):251-8. PubMed ID: 3499330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of double negative T cells and anti-thymocyte serum reverses type 1 diabetes in NOD mice.
    Liu T; Cong M; Sun G; Wang P; Tian Y; Shi W; Li X; You H; Zhang D
    J Transl Med; 2016 Feb; 14():57. PubMed ID: 26911290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N; Minamimura K; Kodaka T; Maki T
    J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory effect of anti-thymocyte globulin monotherapy on peripheral lymphoid tissues of non-obese diabetic mice.
    Vargova L; Zacharovova K; Dovolilova E; Vojtova L; Saudek F
    Transplant Proc; 2011 Nov; 43(9):3277-80. PubMed ID: 22099776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanism of primary anti-Thy-1 antibody responses in vitro induced by uniquely immunogenic thymocyte antigens.
    Isobe KI; Nakashima I; Nagase F; Kato N; Mizoguchi K; Kawashima K; Lake P
    J Immunol; 1984 Mar; 132(3):1100-5. PubMed ID: 6141204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background.
    Makino S; Harada M; Kishimoto Y; Hayashi Y
    Jikken Dobutsu; 1986 Oct; 35(4):495-8. PubMed ID: 3542537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD mice with high incidence of type 1 diabetes are not T lymphocytopenic.
    Satoh J; Shintani S; Nobunaga T; Sugawara S; Makino S; Toyota T; Goto Y
    Tohoku J Exp Med; 1988 Jun; 155(2):151-8. PubMed ID: 3264948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting unresponsiveness to polyclonal T cell-binding immunoglobulins.
    Mysliwietz J; Thierfelder S
    Eur J Immunol; 1998 Jan; 28(1):246-56. PubMed ID: 9485204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes.
    LaFace DM; Peck AB
    Diabetes; 1989 Jul; 38(7):894-901. PubMed ID: 2661286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of the pathogenesis of overt diabetes in NOD mouse].
    Yagi H
    Seikagaku; 1990 Oct; 62(10):1263-8. PubMed ID: 2077067
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural thymocytotoxic autoantibodies in non-obese diabetic (NOD) mice: characterization and fine specificity.
    Lehuen A; Altman J; Bach JF; Carnaud C
    Clin Exp Immunol; 1990 Sep; 81(3):406-11. PubMed ID: 2397610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. I. Effect of anti-Thy-1 antibody on the tissue distribution of lymphocytes.
    Le Gros GS; Prestidge RL; Watson JD
    Immunology; 1983 Dec; 50(4):537-46. PubMed ID: 6606612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.
    Buschard K
    Dan Med Bull; 1985 Jun; 32(3):139-51. PubMed ID: 3160550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice.
    Gagliani N; Jofra T; Posgai AL; Atkinson MA; Battaglia M
    PLoS One; 2015; 10(11):e0142318. PubMed ID: 26580221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.
    Elias D; Markovits D; Reshef T; van der Zee R; Cohen IR
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1576-80. PubMed ID: 2406723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.
    Slattery RM; Kjer-Nielsen L; Allison J; Charlton B; Mandel TE; Miller JF
    Nature; 1990 Jun; 345(6277):724-6. PubMed ID: 1972779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
    Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P
    Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice.
    Nagata M; Yokono K; Hayakawa M; Kawase Y; Hatamori N; Ogawa W; Yonezawa K; Shii K; Baba S
    J Immunol; 1989 Aug; 143(4):1155-62. PubMed ID: 2663991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.